Back To

Martin Waga

Martin Waga has 19 years of experience in the pharmaceutical and healthcare industries. Previously, he was the Senior Manager of Clinical Quality at Adare Pharmaceuticals from May 2017 until the spin-out of Ellodi Pharmaceuticals in September of 2020. He has extensive experience leading quality assurance teams, managing regulatory and pharmacovigilance operations, creating comprehensive quality management systems, hosting third party audits and regulatory inspections, and managing clinical site, supplier, and e-clinical systems audits.

Prior to Adare Pharmaceuticals, Martin led clinical quality assurance and was responsible for pharmacovigilance and quality systems at Luitpold Pharmaceuticals (a division of Daiichi Sankyo). Before that, he was responsible for overseeing quality assurance and regulatory operations at Medidata Solutions Worldwide. Earlier in his career, he was part of the leadership team overseeing quality at ePharmaSolutions and held quality roles in organizations such as Palatin Technologies, Transave Inc., and Schering Plough. He has hosted approximately 300 sponsor, partner, and regulatory inspections in his career which included EMA state authorities, MHRA, FDA, Korean FDA, China FDA and Health Canada. He has a Six Sigma Green Belt and is a member of the American Society of Quality (ASQ) and the Association of Clinical Research Professionals (ACRP). Martin received his undergraduate biology education from Rutgers University.